Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to -$509000.0.

  • Biomerica's Net Cash Flow rose 3565.11% to -$509000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $164000.0, marking a year-over-year increase of 10326.69%. This contributed to the annual value of -$1.8 million for FY2025, which is 6820.23% up from last year.
  • Per Biomerica's latest filing, its Net Cash Flow stood at -$509000.0 for Q4 2025, which was up 3565.11% from $652000.0 recorded in Q3 2025.
  • In the past 5 years, Biomerica's Net Cash Flow ranged from a high of $6.4 million in Q2 2023 and a low of -$4.2 million during Q2 2022
  • Its 5-year average for Net Cash Flow is -$167180.6, with a median of -$728500.0 in 2024.
  • In the last 5 years, Biomerica's Net Cash Flow soared by 83368.48% in 2022 and then tumbled by 111578.95% in 2023.
  • Quarter analysis of 5 years shows Biomerica's Net Cash Flow stood at $2.2 million in 2021, then tumbled by 145.3% to -$1.0 million in 2022, then grew by 14.6% to -$854000.0 in 2023, then rose by 7.38% to -$791000.0 in 2024, then surged by 35.65% to -$509000.0 in 2025.
  • Its Net Cash Flow was -$509000.0 in Q4 2025, compared to $652000.0 in Q3 2025 and -$666000.0 in Q2 2025.